Marlein Miranda Cona

828 total citations
33 papers, 542 citations indexed

About

Marlein Miranda Cona is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Marlein Miranda Cona has authored 33 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Marlein Miranda Cona's work include Radiopharmaceutical Chemistry and Applications (14 papers), Medical Imaging Techniques and Applications (5 papers) and Cancer therapeutics and mechanisms (5 papers). Marlein Miranda Cona is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Medical Imaging Techniques and Applications (5 papers) and Cancer therapeutics and mechanisms (5 papers). Marlein Miranda Cona collaborates with scholars based in Belgium, China and United States. Marlein Miranda Cona's co-authors include Yicheng Ni, Yuanbo Feng, Raymond Oyen, Alfons Verbruggen, Uwe Himmelreich, Peter de Witte, Jie Yu, Jian Zhang, Guy Bormans and Johan Nuyts and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Pharmaceutical Research.

In The Last Decade

Marlein Miranda Cona

32 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlein Miranda Cona Belgium 13 205 202 133 109 96 33 542
Chizuru Sogawa Japan 14 166 0.8× 100 0.5× 119 0.9× 74 0.7× 89 0.9× 20 473
Ziping Sun China 13 118 0.6× 90 0.4× 64 0.5× 90 0.8× 76 0.8× 23 307
Aiqun Liu China 17 392 1.9× 153 0.8× 257 1.9× 110 1.0× 65 0.7× 59 874
Susan Hoppmann United States 12 213 1.0× 158 0.8× 103 0.8× 41 0.4× 61 0.6× 14 471
Marc A. Longino United States 12 91 0.4× 236 1.2× 61 0.5× 141 1.3× 59 0.6× 36 492
Beina Hui China 18 350 1.7× 61 0.3× 270 2.0× 69 0.6× 115 1.2× 30 770
Xiaohui Miao China 11 338 1.6× 88 0.4× 76 0.6× 63 0.6× 173 1.8× 27 717
Jiawen Dai China 6 180 0.9× 126 0.6× 173 1.3× 76 0.7× 155 1.6× 7 547
Deliang Zhang China 12 180 0.9× 62 0.3× 48 0.4× 73 0.7× 41 0.4× 21 442

Countries citing papers authored by Marlein Miranda Cona

Since Specialization
Citations

This map shows the geographic impact of Marlein Miranda Cona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlein Miranda Cona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlein Miranda Cona more than expected).

Fields of papers citing papers by Marlein Miranda Cona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlein Miranda Cona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlein Miranda Cona. The network helps show where Marlein Miranda Cona may publish in the future.

Co-authorship network of co-authors of Marlein Miranda Cona

This figure shows the co-authorship network connecting the top 25 collaborators of Marlein Miranda Cona. A scholar is included among the top collaborators of Marlein Miranda Cona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlein Miranda Cona. Marlein Miranda Cona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cona, Marlein Miranda, Yewei Liu, Ting Yin, et al.. (2016). Differential diagnosis of gallstones by using hypericin as a fluorescent optical imaging agent. World Journal of Gastroenterology. 22(29). 6690–6690. 2 indexed citations
2.
Cona, Marlein Miranda, Yewei Liu, Ting Yin, et al.. (2016). Rat model of cholelithiasis with human gallstones implanted in cholestasis-induced virtual gallbladder. World Journal of Methodology. 6(2). 154–154. 2 indexed citations
3.
Cona, Marlein Miranda, Raymond Oyen, & Yicheng Ni. (2015). Necrosis Avidity of Organic Compounds: A Natural Phenomenon with Exploitable Theragnostic Potentials. Current Medicinal Chemistry. 22(15). 1829–1849. 12 indexed citations
4.
Cona, Marlein Miranda, Yuanbo Feng, Jian Zhang, et al.. (2014). Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction. Drug Delivery. 22(3). 427–435. 10 indexed citations
5.
Cona, Marlein Miranda, Junjie Li, Yuanbo Feng, et al.. (2014). Targetability and Biodistribution of Radioiodinated Hypericin: Comparison between Microdosing and Carrier-Added Preparations. Anti-Cancer Agents in Medicinal Chemistry. 14(6). 852–861. 7 indexed citations
8.
Cona, Marlein Miranda, Junjie Li, Feng Chen, et al.. (2013). A safety study on single intravenous dose of tetrachloro-diphenyl glycoluril [iodogen] dissolved in dimethyl sulphoxide (DMSO). Xenobiotica. 43(8). 730–737. 11 indexed citations
9.
Cona, Marlein Miranda, Yeranddy A. Alpízar, Junjie Li, et al.. (2013). Radioiodinated Hypericin: Its Biodistribution, Necrosis Avidity and Therapeutic Efficacy are Influenced by Formulation. Pharmaceutical Research. 31(2). 278–290. 21 indexed citations
10.
Cona, Marlein Miranda, Bernard Cleynhens, Junjie Li, et al.. (2013). Synthesis and biological evaluation of 68Ga-bis-DOTA-PA as a potential agent for positron emission tomography imaging of necrosis. Nuclear Medicine and Biology. 40(6). 816–822. 7 indexed citations
11.
Cona, Marlein Miranda. (2013). An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications. World Journal of Methodology. 3(4). 45–45. 10 indexed citations
12.
Cona, Marlein Miranda, Michel Koole, Yuanbo Feng, et al.. (2013). Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic. International Journal of Oncology. 44(3). 819–829. 13 indexed citations
13.
Li, Junjie, Marlein Miranda Cona, Feng Chen, et al.. (2012). Exploring Theranostic Potentials of Radioiodinated Hypericin in Rodent Necrosis Models. Theranostics. 2(10). 1010–1019. 43 indexed citations
14.
Li, Junjie, Feng Chen, Marlein Miranda Cona, et al.. (2012). A review on various targeted anticancer therapies. Targeted Oncology. 7(1). 69–85. 56 indexed citations
15.
Li, Junjie, Marlein Miranda Cona, Yuanbo Feng, et al.. (2012). A single-dose toxicity study on non-radioactive iodinated hypericin for a targeted anticancer therapy in mice. Acta Pharmacologica Sinica. 33(12). 1549–1556. 12 indexed citations
16.
Cona, Marlein Miranda, Matthias Bauwens, Yi‐Chao Zheng, et al.. (2012). Study on the Microbial Safety of an Infusion Set for Contrast-Enhanced Imaging. Investigative Radiology. 47(4). 247–251. 8 indexed citations
17.
Chen, Feng, Yingmei Feng, Frederik De Keyzer, et al.. (2012). Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI. PLoS ONE. 7(7). e41140–e41140. 17 indexed citations
18.
Wang, Huaijun, Marlein Miranda Cona, Feng Chen, et al.. (2011). Comparison Between Nonspecific and Necrosis-avid Gadolinium Contrast Agents in Vascular Disrupting Agent-Induced Necrosis of Rodent Tumors at 3.0T. Investigative Radiology. 46(9). 531–538. 8 indexed citations
19.
Cona, Marlein Miranda, Huaijun Wang, Junjie Li, et al.. (2011). Continuing pursuit for ideal systemic anticancer radiotherapeutics. Investigational New Drugs. 30(5). 2050–2065. 7 indexed citations
20.
Cona, Marlein Miranda, et al.. (2007). Comparative evaluation of ior-P1394 and DOTA-TATE for radionuclide therapy. World Journal of Nuclear Medicine. 6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026